Trial Profile
Systemic effects of mild renal insufficiency: the relation between forearm blood flow and ADMA.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2018
Price :
$35
*
At a glance
- Drugs Eprosartan (Primary) ; Rosuvastatin (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 18 Sep 2009 New trial record